One concern i have following on from the recent statements made by management about the 3rd version of pericoach which makes previous versions look like a T-Model ford...
Has anyone realized that the all important 'clinical trails' are being conducted using the inferior T-Model version and not the V3.... How will this effect the trail results (?) ... Why are they formulating clinical evidence using an inferior version (?) Make no mistake the clinical trials are the only thing that will save this company .... the only thing and we are relying on the T Model ford version....!
- Forums
- ASX - By Stock
- ALT
- Question for webinar
Question for webinar, page-25
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online